651 filings
Page 22 of 33
8-K
4q7t6o0
18 Sep 12
Entry into a Material Definitive Agreement
12:00am
DFAN14A
32bjn ipbacqbg2gnim
14 Sep 12
Additional proxy materials by non-management
12:00am
CORRESP
6z98 dpl4gu
7 Sep 12
Correspondence with SEC
12:00am
DEFA14A
y2vwcotyhw6 o6b1
6 Sep 12
Additional proxy soliciting materials
12:00am
DEFA14A
vno01
4 Sep 12
Additional proxy soliciting materials
12:00am
DFAN14A
iaur4ddvtdrk6vwa7iy
29 Aug 12
Additional proxy materials by non-management
12:00am
UPLOAD
7nk1ghtqa9d3aw1gn54d
29 Aug 12
Letter from SEC
12:00am
UPLOAD
iml3qko934eed240
28 Aug 12
Letter from SEC
12:00am
DEFA14A
nq2v53n0e6cgt fg
23 Aug 12
Additional proxy soliciting materials
12:00am
DEFA14A
j6y7odezd3dcgnc
23 Aug 12
Additional proxy soliciting materials
12:00am
UPLOAD
hf3xv7bp0kpa
20 Aug 12
Letter from SEC
12:00am
DFAN14A
7v4zrz4hwp
16 Aug 12
Additional proxy materials by non-management
12:00am
DEFC14A
0yo9nqsn
10 Aug 12
Proxy in contested solicitation
12:00am
8-K
opa9ol03
9 Aug 12
Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results
12:00am
8-K
hd2nnsv
8 Aug 12
Entry into a Material Definitive Agreement
12:00am
DEFM14A
fybjiiqm
7 Aug 12
Proxy related to merger
12:00am
DEFA14A
kqk7pza
3 Aug 12
Additional proxy soliciting materials
12:00am
SC TO-I/A
yivo253ajh xmgw
2 Aug 12
Issuer tender offer statement (amended)
12:00am
SC TO-I/A
f44j09d
31 Jul 12
Issuer tender offer statement (amended)
12:00am